GeoVax Inc
GeoVax Labs Inc. is a clinical-stage biotechnology company based in Smyrna, Georgia, focused on developing innovative human vaccines and immunotherapies to combat infectious diseases and cancer. Their lead oncology program, Gedeptin, has completed enrollment in a multicenter Phase 1/2 clinical trial for advanced head and neck cancers, while their leading infectious disease program, GEO-CM04S1, targets COVID-19 and is currently involved in multiple Phase 2 clinical trials.
The company's extensive development pipeline also includes vaccines against various viruses, such as Mpox, Ebola, and Zika, as well as therapies for different solid tumors. With a commitment to advancing immunology, GeoVax aims to address critical public health challenges through their proprietary technology platforms.
Generated from the website
Also at this address
You might also like
Partial Data by Foursquare.
